Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

CRISPR Therapeutics AG (CRSP) closed at $41.21 in the latest trading session, marking a -1.44% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.47%. Meanwhile ...

Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $43.42, moving -1.83% from the previous trading session. CRISPR Therapeutics (CRSP) saw its shares surge in the last session ...

In the last reported quarter, CRISPR Therapeutics’ earnings beat estimates by 28.79%. Our proven model does not conclusively predict an earnings beat for CRISPR Therapeutics this time around.

DeepSeek was tasked with selecting two stocks investors can buy now and hold long-term due to their growth potential.

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK Leibniz Institute (IPK) and the Karlsruhe Institute of Technology (KIT) ...

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.